Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Prince
Jeremy Lundevall

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2014
Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosomeNelson B Olivier, Roger B Altman, Jonas Noeske, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2006
Design of potent inhibitors of human beta-secretase. Part 2John N Freskos, Yvette M Fobian, Timothy E Benson, et al.
Journal of Medicinal Chemistry|February 16, 2007
Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretaseMichel C Maillard, Roy K Hom, Timothy E Benson, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2006
Design of potent inhibitors of human beta-secretase. Part 1John N Freskos, Yvette M Fobian, Timothy E Benson, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2011
Pyrrolamide DNA gyrase inhibitors: fragment-based nuclear magnetic resonance screening to identify antibacterial agentsAnn E Eakin, Oluyinka Green, Neil Hales, et al.
Chemmedchem|December 22, 2017
Structure-Based Design of Selective Noncovalent CDK12 InhibitorsJeffrey W Johannes, Christopher R Denz, Nancy Su, et al.
Journal of Medicinal Chemistry|May 10, 2017
Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic InhibitorsWilliam McCoull, Roman D Abrams, Erica Anderson, et al.
Journal of Medicinal Chemistry|July 18, 2017
Correction to Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic InhibitorsWilliam McCoull, Roman D Abrams, Erica Anderson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2014
Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosomeNelson B Olivier, Roger B Altman, Jonas Noeske, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2006
Design of potent inhibitors of human beta-secretase. Part 2John N Freskos, Yvette M Fobian, Timothy E Benson, et al.
Journal of Medicinal Chemistry|February 16, 2007
Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretaseMichel C Maillard, Roy K Hom, Timothy E Benson, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2006
Design of potent inhibitors of human beta-secretase. Part 1John N Freskos, Yvette M Fobian, Timothy E Benson, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2011
Pyrrolamide DNA gyrase inhibitors: fragment-based nuclear magnetic resonance screening to identify antibacterial agentsAnn E Eakin, Oluyinka Green, Neil Hales, et al.
Chemmedchem|December 22, 2017
Structure-Based Design of Selective Noncovalent CDK12 InhibitorsJeffrey W Johannes, Christopher R Denz, Nancy Su, et al.
Journal of Medicinal Chemistry|May 10, 2017
Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic InhibitorsWilliam McCoull, Roman D Abrams, Erica Anderson, et al.
Journal of Medicinal Chemistry|July 18, 2017
Correction to Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic InhibitorsWilliam McCoull, Roman D Abrams, Erica Anderson, et al.
Pageof 2